184 related articles for article (PubMed ID: 4522068)
1. The intermittent chemotherapy of tuberculosis with rifampicin regimens on ambulatory basis.
Anastasatu C; Bungeteanu G; Sibila S
Scand J Respir Dis Suppl; 1973; 84():136-9. PubMed ID: 4522068
[No Abstract] [Full Text] [Related]
2. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
Guerra Sanz FJ
Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
[No Abstract] [Full Text] [Related]
3. Clinical aspects of side effects on intermittent rifampicin regimen.
Zierski M
Scand J Respir Dis Suppl; 1973; 84():166-73. PubMed ID: 4522072
[No Abstract] [Full Text] [Related]
4. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions.
Girling DJ
Scand J Respir Dis Suppl; 1973; 84():119-24. PubMed ID: 4522064
[No Abstract] [Full Text] [Related]
5. Side effects observed during intermittent rifampicin therapy.
Stradling P
Scand J Respir Dis Suppl; 1973; 84():129-31. PubMed ID: 4522066
[No Abstract] [Full Text] [Related]
6. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
Nitti V
Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
[No Abstract] [Full Text] [Related]
7. A trial of intermittent rifampicin and ethambutol in retreatment regimens.
Zierski M
Scand J Respir Dis Suppl; 1973; 84():132-5. PubMed ID: 4522067
[No Abstract] [Full Text] [Related]
8. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
Girling DJ
Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
[No Abstract] [Full Text] [Related]
9. Ambulatory intermittent rifampicin and ethambutol in the retreatment of pulmonary tuberculosis.
Sriyabhaya N; Jittinandana A; Kecharanantana P
J Med Assoc Thai; 1974 Nov; 57(11):551-7. PubMed ID: 4452812
[No Abstract] [Full Text] [Related]
10. Intermittent rifampicin treatment of tuberculosis.
Riska N; Mattson K
Scand J Respir Dis Suppl; 1973; 84():140-4. PubMed ID: 4522069
[No Abstract] [Full Text] [Related]
11. Haematological changes during intermittent treatment with rifampicin.
Wislawska-Orlowska B; Pniewski T
Scand J Respir Dis Suppl; 1973; 84():94-7. PubMed ID: 4522080
[No Abstract] [Full Text] [Related]
12. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
Masztalerz J
Pneumonol Pol; 1976 Feb; 44(2):153-61. PubMed ID: 940788
[No Abstract] [Full Text] [Related]
13. [Experimental study of schedules for intermittent administration of rifampicin and ethambutol].
Kozulitsyna TI; Petrov IV
Probl Tuberk; 1976 May; (5):72-5. PubMed ID: 951412
[No Abstract] [Full Text] [Related]
14. Proceedings of the Workshop on Intermittent Drug Therapy and Immunological Implications in Antituberculous Treatment with Rifampicin. Oct. 2-3, 1972 Stockholm. Organized by The Department of Thoracic Medicine, Karolinska Sjukhuset.
Scand J Respir Dis Suppl; 1973; 84():1-193. PubMed ID: 4593267
[No Abstract] [Full Text] [Related]
15. [Comparative daily followed clinical study of treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin. Daily and intermittent method].
Gruzlica; 1975 Dec; 43(12):1067-98. PubMed ID: 1193413
[No Abstract] [Full Text] [Related]
16. [Treatment of chronic pulmonary tuberculosis with rifampin and ethambutol by the continuous and intermittent methods].
Kotowska M; Zelski S
Gruzlica; 1974 May; 42(5):417-9. PubMed ID: 4464230
[No Abstract] [Full Text] [Related]
17. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
[No Abstract] [Full Text] [Related]
18. Preliminary results of a controlled therapeutic trail administering INH-RMP once-weekly, after--or without--an initial period of continuous treatment.
Eule H; Kärnbach E; Kaluza P; Herrmann H
Scand J Respir Dis Suppl; 1973; 84():153-9. PubMed ID: 4593264
[No Abstract] [Full Text] [Related]
19. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
Konno K; Oizumi K; Yamada S; Ogata K; Sato M
Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
[No Abstract] [Full Text] [Related]
20. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
Eule H; Werner E; Winsel K; Iwainsky H
Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
[No Abstract] [Full Text] [Related]
[Next] [New Search]
